UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of COVID-19 pandemic on routine immunization

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.2286-2297

2021

Volltextzugriff (PDF)

Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease

European journal of immunology, 2009-03, Vol.39 (3), p.723-729

2009

Volltextzugriff (PDF)

Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment

PloS one, 2010-06, Vol.5 (6), p.e11237-e11237

2010

Volltextzugriff (PDF)

A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control

BMC public health, 2017-07, Vol.18 (1), p.2-2, Article 2

2017

Volltextzugriff (PDF)

Strengthening national health research systems in the WHO African Region - progress towards universal health coverage

Globalization and health, 2019-07, Vol.15 (1), p.50-50, Article 50

2019

Volltextzugriff (PDF)

Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort

PloS one, 2010-08, Vol.5 (8), p.e12365-e12365

2010

Volltextzugriff (PDF)

Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life

PloS one, 2017-10, Vol.12 (10), p.e0185824-e0185824

2017

Volltextzugriff (PDF)

Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases

The Lancet infectious diseases, 2010-10, Vol.10 (10), p.723-732

2010

Volltextzugriff (PDF)

Unveiling the contributions of immunization for progressing towards Universal Health Coverage

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2036048-2036048

2022

Volltextzugriff (PDF)

C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia

BMC infectious diseases, 2016-03, Vol.16 (110), p.115-115, Article 115

2016

Volltextzugriff (PDF)

Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases

PloS one, 2010-09, Vol.5 (9), p.e12502

2010

Volltextzugriff (PDF)

Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay

Genes and immunity, 2012-01, Vol.13 (1), p.71-82

2012

Volltextzugriff (PDF)

Identification of probable early-onset biomarkers for tuberculosis disease progression

PloS one, 2011-09, Vol.6 (9), p.e25230-e25230

2011

Volltextzugriff (PDF)

Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion

PloS one, 2012-01, Vol.7 (1), p.e30324-e30324

2012

Volltextzugriff (PDF)

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children

Infectious diseases and therapy, 2020-12, Vol.9 (4), p.785-796

2020

Volltextzugriff (PDF)

Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection: A Clinical Trial

American journal of respiratory and critical care medicine, 2013-02, Vol.187 (4), p.439-445

2013

Volltextzugriff (PDF)

Skewing of the CD4+T-Cell Pool Toward Monofunctional Antigen-Specific Responses in Patients With Immune Reconstitution Inflammatory Syndrome in The Gambia

Clinical infectious diseases, 2013-08, Vol.57 (4), p.594-603

2013

Volltextzugriff (PDF)

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study

Human vaccines & immunotherapeutics, 2016-02, Vol.12 (2), p.393-402

2016

Volltextzugriff (PDF)

Antibodies against Haemophilus influenzae type b in The Gambia: Investigating the extent of protection across age groups

Vaccine, 2014-08, Vol.32 (36), p.4620-4624

2014

Volltextzugriff (PDF)

Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment

Genes and immunity, 2015-07, Vol.16 (5), p.347-355

2015

Volltextzugriff (PDF)

Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment

PLoS neglected tropical diseases, 2016-05, Vol.10 (5), p.e0004701

2016

Volltextzugriff (PDF)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (7), p.2135916-2135916

2022

Volltextzugriff (PDF)

Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia

The Pediatric infectious disease journal, 2010-05, Vol.29 (5), p.439-443

2010

Volltextzugriff (PDF)

1 – 25 von 1.330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.009)
Mit Volltextzugriff
(1.041)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Impact of COVID-19 pandemic on routine immunization

Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study

Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment

Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants

A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control

Strengthening national health research systems in the WHO African Region - progress towards universal health coverage

Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort

Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life

Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases

Unveiling the contributions of immunization for progressing towards Universal Health Coverage

C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia

Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases

Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay

Identification of probable early-onset biomarkers for tuberculosis disease progression

Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children

Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection: A Clinical Trial

Skewing of the CD4+T-Cell Pool Toward Monofunctional Antigen-Specific Responses in Patients With Immune Reconstitution Inflammatory Syndrome in The Gambia

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study

Antibodies against Haemophilus influenzae type b in The Gambia: Investigating the extent of protection across age groups

Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment

Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia

Suchergebnisse filtern